Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Cell Biology,Toxicology
Reference41 articles.
1. Anderlini P, Benjamin RS, Wong FC, et al. Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia. J Clin Oncol. 1995;13:2827–34.
2. Cvetkovic RS, Scott LJ. Dexrazoxane: a review of its use for cardioprotection during anthracycline chemotherapy. Drugs. 2005;65:1005–24.
3. Dieras V, Fumoleau P, Romieu G, et al. Randomized parallel study of doxorubicin plus paclitaxel and doxorubicin plus cyclophos phamide as neoadjuvant treatment of patients with breast cancer. J Clin Oncol. 2004;22:4958–65.
4. Ewer MS, Martin FJ, Henderson C, Shapiro CL, Benjamin RS, Gabizon AA. Cardiac safety of liposomal anthracyclines. Semin Oncol. 2004;31(Supplement 13):161–81.
5. Ferrans VJ, Sanchez JA, Herman EH. Pathologic anatomy of animal models of anthracycline-induced cardiotoxicity. In: Muggia FM, Green MD, Speyer JL, eds. Cancer treatment and the heart. Baltimore: The Johns Hopkins University Press; 1992:89–113.
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献